Literature DB >> 25027343

MiR-126 inhibits the invasion of gastric cancer cell in part by targeting Crk.

X Li1, F Wang, Y Qi.   

Abstract

OBJECTIVE: Accumulating evidence has shown that microRNAs (miRNAs) are aberrantly expressed in human gastric cancer and crucial to tumorigenesis. Herein, we identified the role of miR-126 in human gastric cancer (GC) growth and development in vitro.
MATERIALS AND METHODS: MiR-126 expression was investigated in GC tissue samples and cell lines by real-time PCR. Crystal violet test and Transwell assay were conducted to explore the effects of miR-126 on the proliferation and invasion of human GC cell lines, respectively. The impaction of miR-126 over expression on putative target Crk (v-crk sarcoma virus CT10 oncogene homolog) was subsequently confirmed via Western blot. Crk specific siRNA was used to suppress Crk expression.
RESULTS: MiR-126 expression was frequently and markedly downregulated (p < 0.05) in human gastric cancer tissues. Overexpression of miR-126 inhibited GC cells invasion but did not affect its proliferation in vitro. Moreover, overexpression of miR-126 significantly decreased (p < 0.05) the protein levels of Crk, which has previously been identified as a direct target of miR-126. Knockdown of Crk also markedly suppressed GC cells invasion.
CONCLUSIONS: Our results demonstrated that overexpression of miR-126 inhibited GC cells invasion in part by targeting Crk. These findings suggested that miR-126 played major roles in the malignant behavior of GC and it might be a promising therapeutic target of GC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027343

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  MicroRNA-126 inhibits the migration and invasion of endometrial cancer cells by targeting insulin receptor substrate 1.

Authors:  Xiumin Zhao; Danyang Zhu; Cailing Lu; Dewen Yan; Lifeng Li; Zhoufang Chen
Journal:  Oncol Lett       Date:  2015-12-03       Impact factor: 2.967

2.  Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.

Authors:  Haruna Takeda; Alistair G Rust; Jerrold M Ward; Christopher Chin Kuan Yew; Nancy A Jenkins; Neal G Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-22       Impact factor: 11.205

3.  Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.

Authors:  Wei Liu; Zhong-yuan Zhao; Lei Shi; Wen-dan Yuan
Journal:  Diagn Pathol       Date:  2015-07-21       Impact factor: 2.644

4.  MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.

Authors:  Gui-Ming Zhang; Lei Luo; Xue-Mei Ding; Da-Hai Dong; Bin Li; Xiao-Cheng Ma; Li-Jiang Sun
Journal:  Mol Med Rep       Date:  2016-04-22       Impact factor: 2.952

Review 5.  Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Wei Huang; Hsiang-Cheng Chi; Yang-Hsiang Lin; Pei-Hsuan Lu; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

6.  Prognostic value of microRNA-126 and CRK expression in gastric cancer.

Authors:  Shun Yue; Huichang Shi; Jun Han; Tiecheng Zhang; Weiguo Zhu; Dahong Zhang
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

7.  MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy.

Authors:  Mingli Li; Xiangli Meng; Mingxuan Li
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

8.  Trehalose significantly enhances the recovery of serum and serum exosomal miRNA from a paper-based matrix.

Authors:  Shu Hui Neo; Ka Yan Chung; Jia Min Quek; Heng-Phon Too
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

9.  MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression.

Authors:  Ming-Hua Hu; Chen-Yang Ma; Xiao-Ming Wang; Chen-Dong Ye; Guang-Xian Zhang; Lin Chen; Jin-Guo Wang
Journal:  Oncotarget       Date:  2016-10-11

10.  LINC00888 promoted tumorigenicity of melanoma via miR-126/CRK signaling axis.

Authors:  Wei Lu; Xiaohua Tao; Yibin Fan; Yi Tang; Xin Xu; Shasha Fan; Youming Huang; Yong Yu; Dan Luo
Journal:  Onco Targets Ther       Date:  2018-07-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.